Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Single institutions
- Consortia of institutions
- Note: This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.
Overview
Goal: An integrated, iterative multidisciplinary application for developing a microbicide, Pre-Exposure Prophylaxis (PrEP), or Multipurpose Prevention Technology (MPT) non-vaccine biomedical prevention (nBP) product or strategy.
Purpose: To solicit applications from single institutions and consortia of institutions to participate in the Integrated Preclinical Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP). The objective is to create an integrated and iterative multi-disciplinary application with the goal of developing biomedical HIV prevention products or strategies.
Focus Areas:
- Microbicides for HIV prevention
- Pre-Exposure Prophylaxis (PrEP)
- Multipurpose Prevention Technologies (MPT)
- Non-vaccine biomedical prevention strategies
- Products for use in male and/or female genital and gastrointestinal (GI) tracts
- Prevention of HIV acquisition and transmission
Product Delivery Systems:
- Gels
- Films
- Quick dissolving tablets
- Intravaginal rings (IVR)
- Implants
- Oral formulations
- Injections
Eligibility:
- Single institutions
- Consortia of institutions
Note: This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.
What AIDS Vaccine Advocacy Coalition Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $1.04M
- Median grant
- $193K
- Range
- $98K–$555K
- By dollars: Massachusetts 53%, New York 22%, North Carolina 15%. Top recipient cities: Boston, MA; New York, NY; Durham, NC.
Example grants
Clinton Health Access Initiative · Boston, MA
To create a platform
$555K
International AIDS Vaccine Initiative · New York, NY
Hiv vaccine and biom
$227K
Family Health International 360 · Durham, NC
Hiv vaccine and biom
$160K
Internews · Arcata, CA
Hiv vaccine and biom
$98K
Focus Areas & Funding Uses
Fields of Work
- HIV/AIDS
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (RFA-DA-15-005)
AIDS Vaccine Advocacy Coalition Inc
Amount
Varies
Deadline
Deadline not published
Mapplethorpe Foundation Grants: HIV/AIDS Research
The Robert Mapplethorpe Foundation Inc
Amount
Varies
Deadline
Deadline not published
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $3.5M
Deadline
May 28, 2027
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 5, 2027
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
November 16, 2027
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$4,202,000 total
Deadline
May 25, 2029
Ready to apply for Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (RFA-AI-14-025). Now let's win it.